Does definitive local therapy have a role in select HER2+ de novo metastatic breast cancer patients treated with dual anti-HER2 blockade?
Crossref DOI link: https://doi.org/10.1007/s10549-021-06440-z
Published Online: 2021-11-17
Published Print: 2022-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rosier, Luderve
Wang, Yu
Lee, Ji-Hyun
Daily, Karen https://orcid.org/0000-0002-3218-9739
Text and Data Mining valid from 2021-11-17
Version of Record valid from 2021-11-17
Article History
Received: 24 May 2021
Accepted: 1 November 2021
First Online: 17 November 2021
Declarations
:
: The author declares that they have no conflict of interest.